Hybrid™ CPAP Mask Awarded New Fee Schedule
August 15, 2007 04:55 PM Eastern Daylight Time
RESEARCH TRIANGLE PARK,
N.C.--(BUSINESS WIRE)--Teleflex Medical announced today that,
effective July 1, 2007, CMS has issued a new fee schedule and HCPC
reimbursement codes for the Hybrid CPAP Mask. The Hybrid is a
revolutionary interface for use with sleep therapy systems in the
treatment of obstructive sleep apnea. Consisting of an oral cushion
that covers the mouth and two nasal pillows that fit into the
nostrils, the Hybrid design simultaneously addresses two common
concerns with continuous positive airway pressure (CPAP) therapy:
patient comfort and oral leaks. By eliminating the pressure points
across the bridge of the nose and on the forehead, the Hybrid
delivers a more comfortable sleep experience, culminating in better
therapy and a more compliant patient.
The Hybrid HCPC codes issued by CMS are K0553, K0554, K0555, and
A7035.
“We are pleased with the response from
CMS regarding the Hybrid HCPC reimbursement codes. By creating a
brand new CPAP mask category for the Hybrid, CMS is recognizing the
clinical efficacy of this innovative CPAP solution,”
said Tim Hopper, vice president and general manager, Medical
Products business unit of Teleflex Medical.
The Hybrid™ is part of Teleflex Medical’s
existing family of Bravo™ and Nasal-Aire®
II sleep therapy interfaces.
About Teleflex Medical Incorporated
Teleflex Medical Incorporated, a division of Teleflex
Incorporated, is a leading global supplier of disposable medical
products, surgical instruments and medical devices. The division
supports health providers along the continuum of care in three main
areas:
-
Devices for sleep therapy,
respiratory care, anesthesia and urology
-
Surgical instruments and
related services
-
Original equipment
manufacturers
Teleflex Medical markets health care supplies under the HudsonRCI®
and Rüsch®
brand names and surgical instruments and medical devices under the
Beere®, Deknatel®,
KMedic®, Pilling®
and Weck® brands.
About Teleflex Incorporated
Teleflex Incorporated (NYSE:TFX) is a diversified company with
revenues in 2006 of more than $2.5 billion. Teleflex designs,
manufactures and distributes quality-engineered products and
services for the aerospace, automotive, industrial, marine, and
medical markets worldwide. Headquartered in Limerick, Pa., with
operations in 23 countries, Teleflex employs more than 19,000 people
worldwide who focus on providing innovative solutions for customers.
Additional information about Teleflex can be obtained from the
company's website at
www.teleflex.com.
Bravo!™ and Hybrid™
are trademarks of RespCare Inc. Nasal-Aire®
is a registered trademark of Innomed Technologies, Inc. Hudson RCI®
and Deknatel® are registered trademarks
of Teleflex Medical Incorporated. Beere®,
KMedic®, Pilling®
and Weck® are registered trademarks of
Teleflex Incorporated. Rüsch®
is a registered trademark of Willy Rüsch
GmbH.
Contacts
Teleflex Medical
Christianna Vance, 1-919-433-4808
cvance@teleflexmedical.com
|
